Assembly Biosciences, Inc. Prepaid Expense and Other Assets, Current
Assembly Biosciences, Inc. (ASMB) had Prepaid Expense and Other Assets, Current of $6.79 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $6.79M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $5.56M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $5.47M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $3.34M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.79M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.56M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $5.47M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.34M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.49M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $4.50M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $3.42M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $3.26M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.71M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $4.15M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.50M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $3.46M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $3.91M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $6.01M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $4.41M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $5.18M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $7.08M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $7.25M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $7.24M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $6.55M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $6.18M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $6.55M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $6.85M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $4.86M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $5.06M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $4.57M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $5.36M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $5.44M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $6.75M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $4.28M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.99M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $3.34M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.73M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.80M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $898.00K 10-K · filed 2019-02-28 | $897.40K 10-K · filed 2018-03-08 |
| 2017-09-30 | $951.33K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $978.36K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.30M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $611.18K 10-K · filed 2018-03-08 | |
| 2015-12-31 | $704.29K 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |